Mitoguazone, CAS [[459-86-9]]

Produktübersicht

• Artikelname: Mitoguazone, CAS [[459-86-9]]
• Artikelnummer: TGM-T35617
• Hersteller Artikelnummer: T35617
• Alternativnummer: TGM-T35617-1MG,TGM-T35617-5MG,TGM-T35617-10MG,TGM-T35617-25MG,TGM-T35617-50MG,TGM-T35617-100MG,TGM-T35617-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MGBG , Methyl-GAG

Produktbeschreibung

Mitoguazone (Methyl-GAG) is a selective S-adenosyl-methionine decarboxylase inhibitor that penetrates the blood-brain barrier and disrupts polyamine biosynthesis. Mitoguazone is a synthetic polycarbonyl derivative with anti-tumor activity that inhibits the integration of HIV DNA into cellular DNA in monocytes and macrophages, inducing apoptosis. Mitoguazone can be used to prevent acute leukemia, Hodgkin lymphoma and non-Hodgkin lymphoma.

Produkteigenschaften

• Molekulargewicht: 184.2
• Reinheit: 98.00%
• CAS Nummer: [459-86-9]
• Formel: C5H12N8
• Target-Kategorie: Apoptosis|||HIV Protease

Bilder

T35617